Literature DB >> 1310979

Alpha 1-adrenergic receptor-mediated activation of phospholipase D in rat cerebral cortex.

S Llahi1, J N Fain.   

Abstract

We have investigated phospholipase D activity in rat brain cortical slices prelabeled with [32P]orthophosphoric acid. In the presence of ethanol (170 mM), norepinephrine stimulated, in a dose-dependent manner (EC50 = 2.2 microM), the accumulation of [32P]phosphatidylethanol as a result of phospholipase D activity. Norepinephrine-stimulated phospholipase D activity was completely inhibited by prazosin, a specific alpha 1-adrenergic antagonist (Ki = 2.8 nM). However, no accumulation of phosphatidylethanol was observed in the presence of the muscarinic agonist carbachol. The Ca2+ ionophore ionomycin and the protein kinase C activator phorbol 12-myristate 13-acetate (PMA) also stimulated [32P]phosphatidylethanol accumulation in cortical slices, in a dose- and time-dependent manner, whereas the inactive phorbol, 4 alpha-phorbol 12,13-didecanoate, did not stimulate phospholipase D activity. Staurosporine and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, two potent inhibitors of protein kinase C, inhibited PMA and ionomycin stimulation of phospholipase D activity, but did not affect the response to norepinephrine. Furthermore, the effects of PMA and norepinephrine were additive. Differences between PMA and norepinephrine stimulation of phospholipase D activity were also found with regard to the extracellular Ca2+ requirement and time course of phosphatidylethanol accumulation. No stimulation of phospholipase D activity by norepinephrine was observed in slices from cerebellum, a brain area with a low density of alpha 1-adrenergic receptors, while the effect of PMA was greater in the cerebellum than in cortical or hippocampal slices. These results strongly suggest that activation of phospholipase D in cortical slices by norepinephrine and PMA involve different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310979

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Dependence of stimulus-transcription coupling on phospholipase D in agonist-stimulated pituitary cells.

Authors:  M Cesnjaj; L Zheng; K J Catt; S S Stojilkovic
Journal:  Mol Biol Cell       Date:  1995-08       Impact factor: 4.138

2.  Bradykinin stimulates phospholipase D in PC12 cells by a mechanism which is independent of increases in intracellular Ca2+.

Authors:  J Horwitz; B Passarello; M Corso
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

3.  v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters.

Authors:  J Song; D A Foster
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

4.  Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus.

Authors:  D E Pellegrini-Giampietro; S A Torregrossa; F Moroni
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Evidence for lithium-sensitive inositol 4,5-bisphosphate accumulation in muscarinic cholinoceptor-stimulated cerebral-cortex slices.

Authors:  S Jenkinson; R A Challiss; S R Nahorski
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

6.  Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production.

Authors:  T Sugiyama; T Sakai; Y Nozawa; N Oka
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

7.  Psychoses and creativity: is the missing link a biological mechanism related to phospholipids turnover?

Authors:  Bradley S Folley; Mikisha L Doop; Sohee Park
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-12       Impact factor: 4.006

8.  The substrate specificity of brain microsomal phospholipase D.

Authors:  J Horwitz; L L Davis
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.